Endoscopic Sphincterotomy Increases the Risk of Pyogenic Liver Abscess: A Retrospective Study Using Real-World Data
PDF

Keywords

Endoscopic Sphincterotomy
ERCP
Pyogenic Liver Abscess

How to Cite

1.
Ismail A, Sawaf B, Hsieh P, et al. Endoscopic Sphincterotomy Increases the Risk of Pyogenic Liver Abscess: A Retrospective Study Using Real-World Data. ASIDE GI. 2025;2(1):27-32. doi:10.71079/ASIDE.GI.123125111

Abstract

Introduction: Pyogenic liver abscess (PLA) after Endoscopic Retrograde Cholangiopancreatography (ERCP) is a rare infectious adverse event. The association between post-ERCP PLA and endoscopic sphincterotomy has not been extensively studied.

Methods: We conducted a retrospective study using the TriNetX platform by including patients without history of PLA who received ERCP between October 2015 and December 2020. Two groups were made: the endoscopic sphincterotomy (ES) group (patients who received ES during ERCP) and the control group (patients who did not receive ES). The primary outcome was the risk of developing PLA within 1 year of the index ERCP. The secondary outcomes included sepsis, broad-spectrum antibiotics use, need for PLA drainage, and post-ERCP mortality within one year of the index ERCP.

Results: There were 169 patients (1.43%) in the ES group who developed PLA compared to 123 patients (1.04%) in the control group, Relative Risk (RR): 1.37, P-value = 0.007. A total of 241 patients (2.05%) in the ES group developed sepsis compared to 176 patients (1.49%) in the control group, RR: 1.37, P-value = 0.001. A total of 2,954 patients (25.1%) in the ES group received treatment with broad-spectrum antibiotics compared to 2,132 patients (18.1%) in the control group, RR: 1.5, P-value < 0.0001. There was no statistically significant difference in the need for PLA drainage (RR: 1.19, P-value = 0.34) or mortality (RR: 0.969, P-value = 0.49).

Conclusion: ES during ERCP was associated with an increased risk for PLA, sepsis, and broad-spectrum antibiotics use. No mortality difference was found.

PDF

References

1. AbiMansour JP, Martin JA. Biliary Endoscopic Retrograde Cholangiopancreatography. Gastroenterol Clin North Am. 2024: 627 [PMID: 39489579, https://doi.org/10.1016/j.gtc.2024.08.011]

2. Committee ASoP, Chathadi KV, Chandrasekhara V, Acosta RD, Decker GA, Early DS, Eloubeidi MA, Evans JA, Faulx AL, Fanelli RD, Fisher DA, Foley K, Fonkalsrud L, Hwang JH, Jue TL, Khashab MA, Lightdale JR, Muthusamy VR, Pasha SF, Saltzman JR, Sharaf R, Shaukat A, Shergill AK, Wang A, Cash BD, DeWitt JM. The role of ERCP in benign diseases of the biliary tract. Gastrointest Endosc. 2015: 795 [PMID: 25665931, https://doi.org/10.1016/j.gie.2014.11.019]

3. Op den Winkel M, Schirra J, Schulz C, De Toni EN, Steib CJ, Anz D, Mayerle J. Biliary Cannulation in Endoscopic Retrograde Cholangiography: How to Tackle the Difficult Papilla. Dig Dis. 2022: 85 [PMID: 33684915, https://doi.org/10.1159/000515692]

4. Bishay K, Meng ZW, Khan R, Gupta M, Ruan Y, Vaska M, Iannuzzi J, O'Sullivan DE, Mah B, Partridge ACR, Henderson AM, Guo H, Samnani S, DeMarco M, Yuan Y, Elmunzer BJ, Keswani RN, Wani S, Smith ZL, Bridges RJ, Heitman SJ, Hilsden RJ, Brenner DR, Leontiadis GI, Forbes N. Adverse Events Associated With Endoscopic Retrograde Cholangiopancreatography: Systematic Review and Meta-Analysis. Gastroenterology. 2025: 568 [PMID: 39515394, https://doi.org/10.1053/j.gastro.2024.10.033]

5. Lam YH, Wong SK, Lee DW, Lau JY, Chan AC, Yiu RY, Sung JJ, Chung SS. ERCP and pyogenic liver abscess. Gastrointest Endosc. 1999: 340 [PMID: 10462653, https://doi.org/10.1053/ge.1999.v50.98065]

6. Serste T, Bourgeois N, Vanden Eynden F, Coppens E, Deviere J, Le Moine O. Endoscopic drainage of pyogenic liver abscesses with suspected biliary origin. Am J Gastroenterol. 2007: 1209 [PMID: 17378905, https://doi.org/10.1111/j.1572-0241.2007.01140.x]

7. Cerwenka H, Schemmer P. Are our endoscopy patients at risk for pyogenic liver abscess? World J Gastroenterol. 2017: 5457 [PMID: 28852305, https://doi.org/10.3748/wjg.v23.i30.5457]

8. Shi SH, Feng XN, Lai MC, Kong HS, Zheng SS. Biliary diseases as main causes of pyogenic liver abscess caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae. Liver Int. 2017: 727 [PMID: 27718321, https://doi.org/10.1111/liv.13267]

9. Peng YC, Lin CL, Sung FC. Risk of pyogenic liver abscess and endoscopic sphincterotomy: a population-based cohort study. BMJ Open. 2018: e018818 [PMID: 29502088, https://doi.org/10.1136/bmjopen-2017-018818]

10. Vara-Luiz F, Pe D'Arca Barbosa F, Albuquerque A, Fernandes E, Valada Marques A, Spencer V, Nunes G, Fonseca J. Pyogenic Liver Abscess and Delayed Massive Gastrointestinal Bleeding Following Endoscopic Retrograde Cholangiopancreatography (ERCP): Association of Two Rare Complications. Cureus. 2022: e30374 [PMID: 36407183, https://doi.org/10.7759/cureus.30374]

11. Wu CK, Hsu CN, Cho WR, Yang SC, Liu AC, Tai WC, Lee CH, Yang YH, Chuah SK, Liang CM. Increased Risk of Pyogenic Liver Abscess after Endoscopic Sphincterotomy for Treatment of Choledocholithiasis. Infect Drug Resist. 2021: 2121 [PMID: 34135602, https://doi.org/10.2147/IDR.S312545]

12. Kong H, Yu F, Zhang W, Li X. Clinical and microbiological characteristics of pyogenic liver abscess in a tertiary hospital in East China. Medicine (Baltimore). 2017: e8050 [PMID: 28906397, https://doi.org/10.1097/MD.0000000000008050]

13. Wendt S, Bacak M, Petroff D, Lippmann N, Blank V, Seehofer D, Zimmermann L, Lubbert C, Karlas T. Clinical management, pathogen spectrum and outcomes in patients with pyogenic liver abscess in a German tertiary-care hospital. Sci Rep. 2024: 12972 [PMID: 38839980, https://doi.org/10.1038/s41598-024-63819-w]

14. Yin D, Ji C, Zhang S, Wang J, Lu Z, Song X, Jiang H, Lau WY, Liu L. Clinical characteristics and management of 1572 patients with pyogenic liver abscess: A 12-year retrospective study. Liver Int. 2021: 810 [PMID: 33314531, https://doi.org/10.1111/liv.14760]

15. Committee ASoP, Chandrasekhara V, Khashab MA, Muthusamy VR, Acosta RD, Agrawal D, Bruining DH, Eloubeidi MA, Fanelli RD, Faulx AL, Gurudu SR, Kothari S, Lightdale JR, Qumseya BJ, Shaukat A, Wang A, Wani SB, Yang J, DeWitt JM. Adverse events associated with ERCP. Gastrointest Endosc. 2017: 32 [PMID: 27546389, https://doi.org/10.1016/j.gie.2016.06.051]

16. Shen H, Zhu J, Ye F, Xu D, Fang L, Yang J, Lv H, Lou Q, Jin H, Ni M, Zhang X. Biliary Microbial Structure of Gallstone Patients With a History of Endoscopic Sphincterotomy Surgery. Front Cell Infect Microbiol. 2020: 594778 [PMID: 33585269, https://doi.org/10.3389/fcimb.2020.594778]

17. Reinders JS, Kortram K, Vlaminckx B, van Ramshorst B, Gouma DJ, Boerma D. Incidence of bactobilia increases over time after endoscopic sphincterotomy. Dig Surg. 2011: 288 [PMID: 21846989, https://doi.org/10.1159/000329582]

18. Langerth A, Brandt L, Ekbom A, Karlson BM. Late Complications following Endoscopic Sphincterotomy for Choledocholithiasis: A Swedish Population-Based Study. Diagn Ther Endosc. 2014: 745790 [PMID: 25386097, https://doi.org/10.1155/2014/745790]

19. Qian Y, Wong CC, Lai S, Chen H, He X, Sun L, Wu J, Zhou J, Yu J, Liu W, Zhou D, Si J. A retrospective study of pyogenic liver abscess focusing on Klebsiella pneumoniae as a primary pathogen in China from 1994 to 2015. Sci Rep. 2016: 38587 [PMID: 27929082, https://doi.org/10.1038/srep38587]

20. Rupp C, Bode K, Weiss KH, Rudolph G, Bergemann J, Kloeters-Plachky P, Chahoud F, Stremmel W, Gotthardt DN, Sauer P. Microbiological Assessment of Bile and Corresponding Antibiotic Treatment: A Strobe-Compliant Observational Study of 1401 Endoscopic Retrograde Cholangiographies. Medicine (Baltimore). 2016: e2390 [PMID: 26962768, https://doi.org/10.1097/MD.0000000000002390]

21. Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, Moore JP, Fennerty MB, Ryan ME, Shaw MJ, Lande JD, Pheley AM. Complications of endoscopic biliary sphincterotomy. N Engl J Med. 1996: 909 [PMID: 8782497, https://doi.org/10.1056/NEJM199609263351301]

22. Leem G, Sung MJ, Park JH, Kim SJ, Jo JH, Lee HS, Ku NS, Park JY, Bang S, Park SW, Song SY, Chung MJ. Randomized Trial of Prophylactic Antibiotics for Endoscopic Retrograde Cholangiopancreatography in Patients With Biliary Obstruction. Am J Gastroenterol. 2024: 183 [PMID: 37713527, https://doi.org/10.14309/ajg.0000000000002495]

23. Sbeit W, Khoury T, Kadah A, D ML, Nubani A, Mari A, Goldin E, Mahamid M. Long-Term Safety of Endoscopic Biliary Stents for Cholangitis Complicating Choledocholithiasis: A Multi-Center Study. J Clin Med. 2020: [PMID: 32932631, https://doi.org/10.3390/jcm9092953]

24. Rismiller K, Haaga J, Siegel C, Ammori JB. Pyogenic liver abscesses: a contemporary analysis of management strategies at a tertiary institution. HPB (Oxford). 2017: 889 [PMID: 28693978, https://doi.org/10.1016/j.hpb.2017.06.005]

25. Lo JZ, Leow JJ, Ng PL, Lee HQ, Mohd Noor NA, Low JK, Junnarkar SP, Woon WW. Predictors of therapy failure in a series of 741 adult pyogenic liver abscesses. J Hepatobiliary Pancreat Sci. 2015: 156 [PMID: 25339111, https://doi.org/10.1002/jhbp.174]

26. Du ZQ, Zhang LN, Lu Q, Ren YF, Lv Y, Liu XM, Zhang XF. Clinical Charateristics and Outcome of Pyogenic Liver Abscess with Different Size: 15-Year Experience from a Single Center. Sci Rep. 2016: 35890 [PMID: 27775098, https://doi.org/10.1038/srep35890]

27. Nassar M, Abosheaishaa H, Elfert K, Beran A, Ismail A, Mohamed M, Misra A, Essibayi MA, Altschul DJ, Azzam AY. TriNetX and Real-World Evidence: A Critical Review of Its Strengths, Limitations, and Bias Considerations in Clinical Research. ASIDE Intern Med. 2025: 24 [PMID: 40697879, https://doi.org/10.71079/aside.im.03222516]

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2025 Abdellatif Ismail, Bisher Sawaf, Pinghsin Hsieh, Khalid Aloum, Shahem Abbarh, Mhd Kutaiba Albuni, Mohammed Al-Aquily, Mostafa Suhail Najim, Amir Humza Sohail, Saurabh Chandan